Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Clements

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Biotechnology (Reading, Mass.)|January 1, 1992
Influenza vaccinesM L Clements
Annals of the New York Academy of Sciences|May 31, 1995
Combination live respiratory virus vaccinesM L Clements
AIDS Research and Human Retroviruses|November 14, 1998
Lessons for AIDS vaccine development from non-AIDS vaccinesM L Clements-Mann
Comprehensive Therapy|July 1, 1989
Development of new vaccines for AIDSL Garrison, M L Clements
Antimicrobial Agents and Chemotherapy|October 1, 1987
Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virusS D Sears, M L Clements
BMJ (Clinical Research Ed.)|August 26, 1989
Ridding the world of hydroxyquinolinesM E Claeson, M L Clements
Research Report (Health Effects Institute)|January 1, 1988
Susceptibility to virus infection with exposure to nitrogen dioxideT J Kulle, M L Clements
Hypertension (Dallas, Tex. : 1979)|May 1, 1997
Mechanical load opposes angiotensin-mediated decrease in vascular alpha 1-adrenoceptorsM L Clements, J E Faber
Current Topics in Microbiology and Immunology|January 1, 1989
The systemic and mucosal immune response of humans to influenza A virusB R Murphy, M L Clements
Journal of Clinical Microbiology|January 1, 1986
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccineM L Clements, B R Murphy
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Biotechnology (Reading, Mass.)|January 1, 1992
Influenza vaccinesM L Clements
Annals of the New York Academy of Sciences|May 31, 1995
Combination live respiratory virus vaccinesM L Clements
AIDS Research and Human Retroviruses|November 14, 1998
Lessons for AIDS vaccine development from non-AIDS vaccinesM L Clements-Mann
Comprehensive Therapy|July 1, 1989
Development of new vaccines for AIDSL Garrison, M L Clements
Antimicrobial Agents and Chemotherapy|October 1, 1987
Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virusS D Sears, M L Clements
BMJ (Clinical Research Ed.)|August 26, 1989
Ridding the world of hydroxyquinolinesM E Claeson, M L Clements
Research Report (Health Effects Institute)|January 1, 1988
Susceptibility to virus infection with exposure to nitrogen dioxideT J Kulle, M L Clements
Hypertension (Dallas, Tex. : 1979)|May 1, 1997
Mechanical load opposes angiotensin-mediated decrease in vascular alpha 1-adrenoceptorsM L Clements, J E Faber
Current Topics in Microbiology and Immunology|January 1, 1989
The systemic and mucosal immune response of humans to influenza A virusB R Murphy, M L Clements
Journal of Clinical Microbiology|January 1, 1986
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccineM L Clements, B R Murphy
Pageof 13